Replies to post #9524 on Aphria Inc (fka APHA)

[Rowdy2]

You know what the nice thing is tho? APHA sells all the product that they produce, unlike ACB - where much of that company's product goes into inventory and is eventually disposed of.

Because APHA is the cost leader when it comes to quality products, everything that they put on the market sells. This past quarter and the coming quarter they are gearing up to have full production capacity at their new automated facility (ACB does not have any facilities of this calibre, unfortunately) so as part of the transition they shifted production from dried flower for current sale to mother plants for the new facility. Despite this, they still recorded revenue of $73M (ACB only managed to pull together $53M). And yes, CC Pharma was a great and highly profitable acquisition (and one that did not involve highly dilutive share issuances like ACB loves to do).

And yes, APHA recorded a $50M write down, but thank god we didn't incur a $180M write down that bum stock ACB recorded in their latest quarterly results - and i expect more major write downs for bum stock ACB after all those overpriced acquisitions they acquired at the expense of shareholders.

[BubbaInSC]

"Chickens Coming Home To Roost"

Ouch

APHA sold less product than they sold last quarter, LOL. That’s clearly the result of solid management. Thank god for CC pharma, or you’d be trading at $4 right now.

Speaking of management, 50M write-down for your acquisitions? Ouch. How much did Vic and his buddy personally benefit from those transactions? Did you think those chickens would never come home to roost? And here’s a news flash, those write-downs aren’t over yet.